Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine A combined with eltrombopag for primary immune thrombocytopenia
ChiCTR2000040991Phase 4Recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Mar 2021
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cyclosporine and eltrombopag in immune thrombocytopenia (ITP), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: Overall response rate. Started Mar 2021; status: recruiting.
02
Drugs
cyclosporineeltrombopag
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on ChiCTR2000040991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040991.